Projected Growth of the Global Lentiviral Vector Market to Reach $27.71 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the lentiviral vector market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Lentiviral Vector Market By The End Of 2029?

The lentiviral vector market size has experienced significant expansion in recent years. This market is expected to grow from $14.37 billion in 2024 to $16.48 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.7%. Historically, this growth can be ascribed to factors such as the prevalence of genetic disorders, an increasing demand for gene delivery, the expansion within biotech and pharma sectors, substantial clinical trial investment, and various regulatory approvals.

The lentiviral vector market is poised for significant expansion in the coming years. Forecasts indicate it will reach a valuation of $27.71 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.9%. This projected growth during the forecast period is fueled by several factors, including the rise of personalized medicine, advancements in gene editing, increasing demand for rare disease therapies, wider adoption of lentiviral vectors, investments in genomic medicine, and an emphasis on manufacturing scalability. Key trends anticipated for this period encompass heightened research and development activities, their integration into CAR-T cell therapy, the creation of next-generation vectors, their use in vaccine development, and improvements in production technologies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp

Which Business Drivers Are Underpinning The Growth Of The Lentiviral Vector Market?

The future expansion of the lentiviral vectors market is anticipated to be driven by the growing occurrence of chronic illnesses. These are long-standing health issues that generally worsen gradually and can last for extended periods or even a person’s entire life. Factors contributing to the rise in chronic disease prevalence include an aging demographic, unhealthy living habits, increasing urbanization, and various environmental influences. Lentiviral vectors provide adaptable and effective instruments for creating vaccines and therapeutic approaches for chronic conditions, thereby addressing critical medical needs and enhancing patient health. As an illustration, data from September 2024, supplied by the British Heart Foundation, a UK-based cardiovascular research charity, indicates that roughly 7.6 million individuals in the UK suffer from heart and circulatory diseases, comprising around 4 million males and 3.6 million females. These conditions account for approximately 27% of all fatalities in the UK, translating to over 170,000 deaths annually, which is about 480 deaths daily, or one death every three minutes. Consequently, the rising incidence of chronic diseases is a significant catalyst for the growth of the lentiviral vectors market.

What Are The Principal Segment Types In The Lentiviral Vector Market?

The lentiviral vector market covered in this report is segmented –

1) By Product Type: Kits, Reagents And Consumables

2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications

3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes

Subsegments:

1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits

2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors

How Are Industry Trends Steering The Expansion Of The Lentiviral Vector Market?

Major companies operating within the lentiviral vectors market are increasingly concentrating on the development of LV vector production platforms, such as LentiSure, with the goal of improving the efficiency and stability of lentivirus vector generation for cell-based immuno-oncology treatments. LentiSure, specifically, is an LV vector production system designed for generating lentiviral vectors used in cell-based immuno-oncology therapies, engineered to boost effectiveness and resilience in vector creation. For instance, in May 2023, Yposkesi sk pharmteco, a France-based manufacturer of viral vectors, launched LentiSure, an advanced platform aimed at enhancing the production of lentiviral (LV) vectors to improve the durability and efficiency of lentivirus output. This platform addresses the escalating demand for reliable and economically scalable viral-vector manufacturing technologies in cell and gene therapies. It also ensures consistent product quality, with average titers at cell culture harvest at 10e7 IG/mL bioreactor volume, thereby guaranteeing higher productivity and success for cell therapy developers.

Which Companies Are Contributing Significantly To The Lentiviral Vector Market Growth?

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report

Which Region Offers The Most Opportunity For Lentiviral Vector Market Expansion?

North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14742&type=smp

Browse Through More Reports Similar to the Global Lentiviral Vector Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Vector Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vector-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795